9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 1 filers reported holding 9 METERS BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,700,000 | -10.0% | 12,561,009 | +9.2% | 0.00% | – |
| Q2 2022 | $3,000,000 | -57.2% | 11,502,229 | -1.7% | 0.00% | – |
| Q1 2022 | $7,011,000 | -39.5% | 11,698,118 | -1.2% | 0.00% | – |
| Q4 2021 | $11,593,000 | -23.6% | 11,844,484 | +1.5% | 0.00% | – |
| Q3 2021 | $15,171,000 | +26.2% | 11,669,668 | +6.8% | 0.00% | – |
| Q2 2021 | $12,018,000 | +14.3% | 10,925,887 | +21.5% | 0.00% | – |
| Q1 2021 | $10,518,000 | +70.2% | 8,989,097 | +25.0% | 0.00% | – |
| Q4 2020 | $6,178,000 | +890.1% | 7,192,570 | +839.4% | 0.00% | – |
| Q3 2020 | $624,000 | +52.2% | 765,641 | +7.1% | 0.00% | – |
| Q2 2020 | $410,000 | – | 715,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 25,716,755 | $20,489,000 | 0.26% |
| Atlas Private Wealth Advisors | 20,000 | $16,000 | 0.01% |
| Lindbrook Capital, LLC | 40,000 | $33,000 | 0.01% |
| Prospera Financial Services Inc | 15,000 | $12,000 | 0.01% |
| Virtu Financial LLC | 37,982 | $31,000 | 0.01% |
| Cypress Wealth Services, LLC | 25,500 | $21,000 | 0.01% |
| ExodusPoint Capital Management, LP | 180,096 | $147,000 | 0.00% |
| Qube Research & Technologies Ltd | 232,248 | $189,000 | 0.00% |
| Ashfield Capital Partners, LLC | 33,353 | $27,000 | 0.00% |
| Heritage Wealth Advisors | 20,000 | $16,300,000 | 0.00% |